SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (4261)1/4/1998 3:02:00 AM
From: blankmind  Read Replies (3) of 23519
 
-- Earnings of $.90 & $1.62; for '98 & '99, are good enough for me. And good enought to support a $40 share price. Especially when VVUS would have close to $180 mill in cash & equiv if First Call's scenario played out.

-- Also, shorts are toast.

-- VVUS held above $11. Despite being hit viciously by short sellers and the most innane Barron's article.

-- Over 10 mill shares shorted vs. 34 mill or so outstanding? And mngmt has a 2 million share buyback underway. So far, only 400k shares confirmed have been bought back. They'll give new numbers on 1/19/98. What's even better, is that mngmt said they can always go beyond the 2 mill share buyback.

-- Where in the world are the shorts going to get the shares to cover?

Out.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext